1887
  1. Home
  2. A-Z Publications
  3. Journal of Emergency Medicine, Trauma and Acute Care
  4. Volume 2024, Issue 8
  5. Article
8 - The 3rd Mustansiriyah International Dental Conference
  • ISSN: 1999-7086
  • EISSN: 1999-7094

Abstract

Adenoid cystic carcinoma (ACC) is a type of salivary gland cancer with a poor long-term survival rate. Understanding the pathophysiology of this type of cancer will expand the available therapy options. The B-cell lymphoma 2 (Bcl-2) protein produces this early component within the Bcl-2 family of regulatory proteins, which can stimulate proapoptotic or inhibit cell death.

The goal of this study was to detect the expression of Bcl-2 in ACC of the salivary glands and relate the results to clinicopathological characteristics.

This study examined 35 histopathologically verified ACC of the salivary glands in the oral pathology laboratory at Specialist Surgical Hospital for the period (2011–2015). Bcl-2 expressions were investigated using an immunohistochemical analysis method. The expressions were correlated with clinical and histological evidence using the Statistical Package for the Social Sciences (SPSS) software version (20.0).

The expression of Bcl-2 revealed the high frequency of tumors with free margin was in the mild score and the high frequency of tumor with neural invasion was in the moderate score. Additionally, the distribution of the location and type elements along with interesting comparisons was provided. The neural invasion group’s distribution of the tumor revealed high significant difference.

Adenoid cystic malignancy expresses antiapoptotic Bcl-2. Its expression may be useful in predicting behavior and establishing ACC-specific treatment.

© 2024 Abdulhussain, Al Zubidi, Shareef, licensee HBKU Press.
Loading

Article metrics loading...

/content/journals/10.5339/jemtac.2024.midc.14
2024-12-31
2025-01-18
Loading full text...

Full text loading...

/deliver/fulltext/jemtac/2024/8/jemtac.2024.midc.14.html?itemId=/content/journals/10.5339/jemtac.2024.midc.14&mimeType=html&fmt=ahah

References

  1. Abdulhussain MM. Immunohistochemical Expression of CEA in Head and Neck Squamous and Adenosquamous Cell Carcinomahttps. MDJ. 2018; 15:(1):90–6. https://doi.org/10.32828/mdj.v15i1.738
     [Google Scholar]
  2. Liang L, Weng J, You Y, He Q, Fan Y, Liao G. Role of Noxa in Proliferation, Apoptosis, and Autophagy in Human Adenoid Cystic Carcinoma. J Oral Pathol Med. 2019Jan; 48:(1):52–9. https://doi.org/10.1111/jop.12787
     [Google Scholar]
  3. Abed MI, Al-Azzawi LM. Comparative Study of CD105 and Ki-67 in Adenoid Cystic Carcinoma and Polymorphous Low Grade Adenocarcinoma of the Salivary Glands. J Unvi Baby Pure Appl Sci. 2019; 27:(3):1–9.
    [Google Scholar]
  4. Neville BW, Damm DD, Allen CM, Chi AC. Oral and Maxillofacial Pathology-E-Book. Elsevier Health Sciences; 2023May24.
    [Google Scholar]
  5. Abdulhussain MM, Mohsen AS. Immunohistochemical Evaluation of Bcl-2 in Mucoepidermoid Carcinoma and Adenoid Cystic Carcinoma of Salivary Glands. J Int Dent Med Res. 2020; 13:(1):180–7.
    [Google Scholar]
  6. Rasul F, Wahid SM, Imran I, Rizvi Z, Jaffar R, Anwar A. Immunohistochemical Expression of BCL-2 in Malignant Salivary Gland Tumors. J Islamabad Med Dent Coll. 2021Mar31; 10:(1):15–22. https://doi.org/10.35787/jimdc.v10i1.542
     [Google Scholar]
  7. Lloyd S, Yu JB, Wilson LD, Decker RH. Determinants and Patterns of Survival in Adenoid Cystic Carcinoma of the Head and Neck, Including an Analysis of Adjuvant Radiation Therapy. Am J Clin Oncol. 2011; 34:76–81. https://doi.org/10.1097/COC.0b013e3181d26d45
     [Google Scholar]
  8. Xie X, Nordgård S, Clausen F, Petter O, Boysen M. Prognostic Significance of Bax and Bcl-2 Expressions in Adenoid Cystic Carcinoma of Major and Minor Salivary Glands of Nasal and Oral Epithelium. Open Otorhinolaryngol. J. 2010; 4:(1):20–6. https://doi.org/10.2174/1874428101004010020
     [Google Scholar]
  9. Borowska B, Filip A, Wojcierowski J, Smolen A, Korobowicz E. Estimation of Prognostic Value of Bcl-a L gene Expression in Non-Small Lung Cancer. Lung Cancer. 2006; 51:61–9. https://doi.org/10.1016/j.lungcan.2005.08.010
     [Google Scholar]
  10. Ibrahim TR, Ahmed MM, Hegazy AA. Diagnostic Utility of Immunohistochemical Expressions of IMP3 Versus DOG1 and p63 in Salivary Gland Tumors. Turk Patoloji Derg. 2020; 36:(3):227–36. https://doi.org/10.5146/tjpath.2020.01496
     [Google Scholar]
  11. Shum JW, Chatzistefanou I, Qaisi M, Lubek JE, Ord RA. Adenoid Cystic Carcinoma of the Minor Salivary Glands: A Retrospective Series of 29 Cases and Review of the Literature. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 121:210–4. https://doi.org/10.1016/j.oooo.2015.10.003
     [Google Scholar]
  12. Goulart-Filho JA, Montalli VA, Passador-Santos F, de Araújo NS, de Araújo VC. Role of Apoptotic, Autophagic and Senescence Pathways in Minor Salivary Gland Adenoid Cystic Carcinoma. Diagnost Pathol. 2019Dec; 14:1–6. https://doi.org/10.1186/s13000-019-0796-2
     [Google Scholar]
  13. Yin LX, Ha PK. Genetic Alterations in Salivary Gland Cancers. Cancer. 2016; 122:1822–31. https://doi.org/10.1002/cncr.29890
     [Google Scholar]
  14. Gnepp DR. Diagnostic Surgical Pathology of the Head and Neck. PhiladelphiaWB Saunders2001379.
    [Google Scholar]
  15. Triantafillidou K, Dimitrakopoulos J, Iordanidis F, Koufogiannis D. Management of Adenoid Cystic Carcinoma of Minor Salivary Glands. J Oral Maxillofac Surg. 2006; 64:1114–20. https://doi.org/10.1016/j.joms.2005.06.017
     [Google Scholar]
  16. Mils SE, Stenberg S. Diagnostic Surgical Pathology. PhiladelphiaLippincott Williams and Wilkins2004:946–7.
    [Google Scholar]
  17. Lu QL, Abel P, Foster CS, Lalani EN. Bcl-2: Role in Epithelial Differentiation and Oncogenesis. Hom Pathol. 1996; 27:102–10. https://doi.org/10.1016/s0046-8177(96)90362-7
     [Google Scholar]
  18. Carlinfante G, Lazzaretti M, Ferrari S, Bianchi B, Crafa P. P53, Bcl-2 and Ki-67 Expression in Adenoid Cystic. Pathol Res Pract. 2005; 200:(11–12):791–9. https://dio.org/10.1016/j.prp.2004.08.008
     [Google Scholar]
  19. Coultas L, Strasser A. The Role of the Bcl-2 Protein Family in Cancer. Sem Cancer Biol. 2003; 13:(2):115–23. https://doi.org/10.1016/s1044-579x(02)00129-3
     [Google Scholar]
  20. Nagler RM, Kerner H, Ben-Eliezer S, Minkov I, Ben-Itzhak O. Prognosticroleofapoptotic, Bcl-2, c-erbB-2 and p53 Tumor Markers in Salivary Gland Malignancies. Oncology. 2003; 64:(4):389–98. https://doi.org/10.1159/000070298
     [Google Scholar]
  21. Jiang LC, Huang SY, Zhang DS, Zhang SH, Li WG, Zheng PH, Chen ZW. Expression of Beclin 1 in Primary Salivary Adenoid Cystic Carcinoma and Its Relation to Bcl-2 and p53 and Prognosis. Braz J Med Biol Res. 2014; 47:(3):1–6. https://doi.org/10.1590/1414-431X20133231
     [Google Scholar]
/content/journals/10.5339/jemtac.2024.midc.14
Loading
Assessment of the expression of Bcl-2 with clinicopathological factors in adenoid cystic carcinoma of salivary glands: A retrospective study
Journal of Emergency Medicine, Trauma and Acute Care 2024, 14 (2024); https://doi.org/10.5339/jemtac.2024.midc.14
/content/journals/10.5339/jemtac.2024.midc.14
/content/journals/10.5339/jemtac.2024.midc.14
Loading

Data & Media loading...

Keyword(s): adenoid cystic carcinoma, antiapoptosis, Bcl-2, clinicopathological parameters and immunohistochemistry

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error